Drugs / vermofenib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06763029 | Feb 2025 → Dec 2026 expected | colorectal cancer | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | vermofenib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06763029 ↗ |
| Route | Oral | “Vermofenil 960mg orally twice daily” NCT06763029 ↗ |